Published in Blood on December 01, 1982
Cardiac Surgery: In Vivo Titration of Protamine (Protamine) | NCT00684450
Pharmacokinetics, toxicity, and activity of intravenous dextran sulfate in human immunodeficiency virus infection. Antimicrob Agents Chemother (1991) 1.48
Tight coupling of thrombin-induced acid hydrolase secretion and phosphatidate synthesis to receptor occupancy in human platelets. Biochem J (1984) 1.23
Anticoagulation in chronic kidney disease patients-the practical aspects. Clin Kidney J (2014) 0.95
Avoidance of bleeding during surgery in patients receiving anticoagulant and/or antiplatelet therapy: pharmacokinetic and pharmacodynamic considerations. Clin Pharmacokinet (2004) 0.95
Inositol lipids, phosphatidate and diacylglycerol share stearoylarachidonoylglycerol as a common backbone in thrombin-stimulated human platelets. Biochem J (1984) 0.91
Tinzaparin and other low-molecular-weight heparins: what is the evidence for differential dependence on renal clearance? Exp Hematol Oncol (2013) 0.84
Off-pump coronary artery bypass grafting using continuous heparin infusion. Indian Heart J (2016) 0.78
Frequency and predictors of thrombus inside the guiding catheter during interventional procedures: an optical coherence tomography study. Int J Cardiovasc Imaging (2014) 0.76
Heparin in interventional radiology: a therapy in evolution. Semin Intervent Radiol (2005) 0.75
Use of the activated clotting time in anticoagulation monitoring of intravascular procedures. Tex Heart Inst J (1993) 0.75
The Use of Heparin during Endovascular Peripheral Arterial Interventions: A Synopsis. Scientifica (Cairo) (2016) 0.75
Development of a population pharmacokinetic-pharmacodynamic model of a single bolus dose of unfractionated heparin in paediatric patients. Br J Clin Pharmacol (2016) 0.75
Normothermic cardiopulmonary bypass increases heparin requirements necessary to maintain anticoagulation. J Clin Monit Comput (1998) 0.75
The symptom-association probability: an improved method for symptom analysis of 24-hour esophageal pH data. Gastroenterology (1994) 4.35
Human blood platelet adhesion to artery subendothelium is mediated by factor VIII-Von Willebrand factor bound to the subendothelium. Nature (1979) 3.06
CD63 antigen. A novel lysosomal membrane glycoprotein, cloned by a screening procedure for intracellular antigens in eukaryotic cells. J Biol Chem (1991) 2.82
Human blood platelets showing no response to collagen fail to express surface glycoprotein Ia. Nature (1986) 2.31
Immunological characterization of purified anti-haemophilic factor A (factor VIII) which corrects abnormal platelet retention in Von Willebrand's disease. Nat New Biol (1972) 2.30
Protein A is the von Willebrand factor binding protein on Staphylococcus aureus. Blood (2000) 2.12
Comparing subcutaneous danaparoid with intravenous unfractionated heparin for the treatment of venous thromboembolism. A randomized controlled trial. Ann Intern Med (1995) 1.93
Multivesicular bodies are an intermediate stage in the formation of platelet alpha-granules. Blood (1998) 1.88
Exploratory phase III study of paclitaxel and cisplatin versus paclitaxel and carboplatin in advanced ovarian cancer. J Clin Oncol (2000) 1.72
von Willebrand factor proteolysis is deficient in classic, but not in bone marrow transplantation-associated, thrombotic thrombocytopenic purpura. Blood (1999) 1.62
Structure-function relationship of human von Willebrand factor. Blood (1987) 1.60
Blood platelets are concentrated near the wall and red blood cells, in the center in flowing blood. Arteriosclerosis (1989) 1.57
Heterozygosity for a hereditary hemochromatosis gene is associated with cardiovascular death in women. Circulation (1999) 1.54
Increased thromboxane biosynthesis in patients with acute cerebral ischemia. Stroke (1993) 1.54
Concordance of phenprocoumon dosage in married couples. BMJ (1997) 1.51
Gastrointestinal motility and gastric tube feeding in mechanically ventilated patients. Crit Care Med (1998) 1.49
Plasminogen activator inhibitor 4G polymorphism is associated with decreased risk of cerebrovascular mortality in older women. Circulation (2000) 1.45
What is the optimal time window in symptom analysis of 24-hour esophageal pressure and pH data? Dig Dis Sci (1994) 1.45
A perfusion chamber developed to investigate platelet interaction in flowing blood with human vessel wall cells, their extracellular matrix, and purified components. J Lab Clin Med (1983) 1.44
Role of factor VIII-von Willebrand factor and fibronectin in the interaction of platelets in flowing blood with monomeric and fibrillar human collagen types I and III. J Clin Invest (1985) 1.40
[Thrombotic thrombocytopenic purpura: a benign disease with a very severe acute phase]. Ned Tijdschr Geneeskd (1990) 1.39
The role of collagen in thrombosis and hemostasis. J Thromb Haemost (2004) 1.38
Responses to gastric distension in functional dyspepsia. Gut (1998) 1.32
The hemostatic plug. Semin Hematol (1977) 1.31
Heterogeneity of human factor VIII. I. Characterization of factor VIII present in the supernatant of cryoprecipitate. J Lab Clin Med (1978) 1.30
Prevention of infection by trimethoprim-sulfamethoxazole plus amphotericin B in patients with acute nonlymphocytic leukaemia. Ann Intern Med (1981) 1.29
The origin of P-selectin as a circulating plasma protein. Thromb Haemost (1997) 1.25
Increased platelet deposition on atherosclerotic coronary arteries. J Clin Invest (1994) 1.23
A new method to study shape recovery of red blood cells using multiple optical trapping. Biophys J (1995) 1.23
Red blood cell size is important for adherence of blood platelets to artery subendothelium. Blood (1983) 1.23
Platelet adhesion to collagen types I through VIII under conditions of stasis and flow is mediated by GPIa/IIa (alpha 2 beta 1-integrin). Blood (1994) 1.21
Deficiency of platelet membrane glycoprotein Ia associated with a decreased platelet adhesion to subendothelium: a defect in platelet spreading. Blood (1986) 1.20
Crystal structure of the A3 domain of human von Willebrand factor: implications for collagen binding. Structure (1997) 1.20
The role of platelet membrane glycoproteins Ib and IIb-IIIa in platelet adherence to human artery subendothelium. Br J Haematol (1986) 1.20
Patients with a prolonged bleeding time and normal aggregation tests may have storage pool deficiency: studies on one hundred six patients. Blood (1987) 1.18
Platelet and fibrin deposition at the damaged vessel wall: cooperative substrates for neutrophil adhesion under flow conditions. Blood (1997) 1.17
The affinity and stoichiometry of binding of human factor VIII to von Willebrand factor. Blood (1995) 1.16
Structural studies on the O-linked carbohydrate chains of human platelet glycocalicin. Eur J Biochem (1984) 1.14
Bleeding symptoms in carriers of hemophilia A and B. Thromb Haemost (1988) 1.14
Proteolytic cleavage of recombinant type 2A von Willebrand factor mutants R834W and R834Q: inhibition by doxycycline and by monoclonal antibody VP-1. Blood (1997) 1.12
Subendothelial proteins and platelet adhesion. von Willebrand factor and fibronectin, not thrombospondin, are involved in platelet adhesion to extracellular matrix of human vascular endothelial cells. Arteriosclerosis (1986) 1.12
Thrombin stimulates glucose transport in human platelets via the translocation of the glucose transporter GLUT-3 from alpha-granules to the cell surface. J Cell Biol (1997) 1.12
Hemostasis in menstrual endometrium: a review. Obstet Gynecol Surv (1982) 1.11
Soluble adhesion molecules reflect endothelial cell activation in ischemic stroke and in carotid atherosclerosis. Stroke (1997) 1.11
Factor VIII binds to von Willebrand factor via its Mr-80,000 light chain. Eur J Biochem (1987) 1.10
DDAVP enhances platelet adherence and platelet aggregate growth on human artery subendothelium. Blood (1984) 1.10
Von Willebrand factor in the vessel wall mediates platelet adherence. Blood (1985) 1.09
Thrombosis and hemostasis in renal disease. Kidney Int (1994) 1.09
Barostat review. Dig Dis Sci (1997) 1.07
Nitric oxide functions as an inhibitor of platelet adhesion under flow conditions. Circulation (1992) 1.07
Identification of risk factors for bleeding during treatment of acute venous thromboembolism with heparin or low molecular weight heparin. Blood (1991) 1.07
Identification of the collagen-binding site of the von Willebrand factor A3-domain. J Biol Chem (2000) 1.06
Compliance of the proximal stomach and dyspeptic symptoms in patients with type I diabetes mellitus. Dig Dis Sci (1995) 1.05
Immunocytochemical localization of fibrinogen, platelet factor 4, and beta thromboglobulin in thin frozen sections of human blood platelets. J Clin Invest (1983) 1.05
Fibronectin in artery subendothelium is important for platelet adhesion. Blood (1985) 1.04
Adenine nucleotide metabolism of blood platelets. 8. Transport of adenine into human platelets. Biochim Biophys Acta (1973) 1.04
A3 domain is essential for interaction of von Willebrand factor with collagen type III. Thromb Haemost (1996) 1.04
Binding of factor VIII-von Willebrand factor to human arterial subendothelium precedes increased platelet adhesion and enhances platelet spreading. J Lab Clin Med (1981) 1.02
Red blood cell deformability influences platelets--vessel wall interaction in flowing blood. Blood (1984) 1.02
Adhesion of platelets to human artery subendothelium: effect of factor VIII-von Willebrand factor of various multimeric composition. Blood (1984) 1.01
Immunocytochemical localization of albumin and factor XIII in thin cryo sections of human blood platelets. Thromb Haemost (1984) 1.01
Proximal gastric motor activity in response to a liquid meal in type I diabetes mellitus with autonomic neuropathy. Dig Dis Sci (1998) 1.01
Inactivation of human factor VIII by activated protein C. Cofactor activity of protein S and protective effect of von Willebrand factor. J Clin Invest (1988) 1.01
Stomach distension increases efferent muscle sympathetic nerve activity and blood pressure in healthy humans. J Neurol Sci (1998) 1.01
Platelet adherence to subendothelium of human arteries in pulsatile and steady flow. Thromb Res (1981) 0.99
Effect of ICS 205-930 (a specific 5-HT3 receptor antagonist) on gastric emptying of a solid meal in normal subjects. Gut (1988) 0.98
Function of the proximal stomach after Nissen fundoplication. Br J Surg (1998) 0.97
Responses of platelets to strains of streptococcus sanguis: findings in healthy subjects, Bernard-Soulier, Glanzmann's, and collagen-unresponsive patients. Thromb Haemost (1987) 0.97
Neutrophil adhesion to fibrinogen and fibrin under flow conditions is diminished by activation and L-selectin shedding. Blood (1997) 0.97
Excessive urinary albumin levels are associated with future cardiovascular mortality in postmenopausal women. Circulation (2001) 0.97
Survival of 125iodine-labeled Factor VIII in normals and patients with classic hemophilia. Observations on the heterogeneity of human Factor VIII. J Clin Invest (1978) 0.97
The half-life of infused factor VIII is shorter in hemophiliac patients with blood group O than in those with blood group A. Thromb Haemost (2000) 0.96
Absence of ligands bound to glycoprotein IIB-IIIA on the exposed surface of a thrombus may limit thrombus growth in flowing blood. J Clin Invest (1994) 0.96
Thrombogenicity of vascular cells. Comparison between endothelial cells isolated from different sources and smooth muscle cells and fibroblasts. Arteriosclerosis (1990) 0.95
Factor VIII and von Willebrand factor. Thromb Haemost (1998) 0.95
Functional domains on von Willebrand factor. Recognition of discrete tryptic fragments by monoclonal antibodies that inhibit interaction of von Willebrand factor with platelets and with collagen. J Clin Invest (1984) 0.94
Fibronectin is required for platelet adhesion and for thrombus formation on subendothelium and collagen surfaces. Blood (1987) 0.94
The effect of activated prothrombin-complex concentrate (FEIBA) on joint and muscle bleeding in patients with hemophilia A and antibodies to factor VIII. A double-blind clinical trial. N Engl J Med (1981) 0.94
Binding of adenosine diphosphate to human blood platelets and to isolated blood platelet membranes. Biochim Biophys Acta (1980) 0.93
Activation of the coagulation mechanism on tumor necrosis factor-stimulated cultured endothelial cells and their extracellular matrix. The role of flow and factor IX/IXa. J Biol Chem (1991) 0.93
Characteristics of platelet factor 3 release during ADP-induced aggregation. Comparison with 5 hydroxytryptamine release. Thromb Diath Haemorrh (1970) 0.93
Meningeal involvement in patients with acute nonlymphocytic leukemia. Incidence, management, and predictive factors. Cancer (1985) 0.93
Gastric emptying and postprandial symptoms after Billroth II resection. Surgery (1987) 0.92
Platelet adhesion to multimeric and dimeric von Willebrand factor and to collagen type III preincubated with von Willebrand factor. Arterioscler Thromb Vasc Biol (1996) 0.92
Multiple substitutions in the von Willebrand factor gene that mimic the pseudogene sequence. Proc Natl Acad Sci U S A (1994) 0.92
Transport and metabolism of adenosine in human blood platelets. Biochim Biophys Acta (1976) 0.92
Activated factor X and thrombin formation triggered by tissue factor on endothelial cell matrix in a flow model: effect of the tissue factor pathway inhibitor. Blood (1994) 0.92
Thrombus formation and platelet-vessel wall interaction in the nephrotic syndrome under flow conditions. J Clin Invest (1994) 0.92
Gastric emptying and dyspeptic symptoms in the irritable bowel syndrome. Scand J Gastroenterol (1992) 0.91
Morphology of the hemostatic plug in human skin wounds: transformation of the plug. Lab Invest (1979) 0.91
Thrombospondin-platelet interactions. Role of divalent cations, wall shear rate, and platelet membrane glycoproteins. J Clin Invest (1993) 0.91
Kinetics of factor VIII-von Willebrand factor association. Blood (1996) 0.91
Platelet adhesion to laminin: role of Ca2+ and Mg2+ ions, shear rate, and platelet membrane glycoproteins. Blood (1992) 0.90
Glycoprotein Ib, von Willebrand factor, and glycoprotein IIb:IIIa are all involved in platelet adhesion to fibrin in flowing whole blood. Blood (1990) 0.90
On the role of von Willebrand factor in promoting platelet adhesion to fibrin in flowing blood. Blood (1995) 0.90